Overview - 2015 Next Generation Dx Summit

2015 Archived Content

OVERVIEW | DOWNLOAD BROCHURE | SPEAKERS | SHORT COURSES

PAST EVENT HIGHLIGHTS

Stories and Videos from Next Generation Dx Summit 2015

Cross-Industry Diagnostic Experts Discuss Balancing Innovation & Regulation

2015 PAMA Update: Impact on Molecular Tests

Next Generation Dx Summit 2015 Exhibitor Testimonials

2015 Plenary Session

In the Best Interest of the Patient: Balancing Innovation and Regulation

Co-Organized with

Moderator: Elaine Lyon, Ph.D., Medical Director, Molecular Genetics, ARUP (AMP 2014 President and Member, AMP Professional Relations Committee)

Panelists:

Jordan S. Laser, M.D., Medical Director, Pathology and Laboratory Medicine, North Shore Long Island Jewish Health System (Member, AMP Professional Relations Committee)

Jamie McDonald, MS, Licensed Genetic Counselor, Co-Director, HHT Center of Excellence; Assistant Professor, Department of Pathology, University of Utah

Stephen Day Stephen P. Day, Ph.D., IVD Consultant (Member, AMP Professional Relations Committee)

IMPACT OF PAMA REGULATIONS ON IVDS

Moderator: Bruce Quinn, M.D., Ph.D., Senior Director, FaegreBD Consulting

The Impact of PAMA on Molecular Tests

Julie Khani Julie Khani, Senior Vice President, American Clinical Laboratory Association

Panelists:

John F. Warren, Senior Director, McDermott+Consulting LLC

Donna Polizio, Senior Director, Managed Care & Reimbursement, Genomic Health

Paul W. Radensky, M.D., Partner, Health Products Regulation Group, McDermott Will & Emery LLP

Event Features

Form partnerships with major players in the evolving areas of diagnostics
Gain a comprehensive up-to-date view of diagnostics
Gather important industry announcements
Network with 950+ attendees
from around the world
Hear late-breaking news on LDTs and PAMA in the Plenary session
Connect with attendees using CHI’s Intro-Net
Review latest technologies in the poster competition
Choose from a range of in-depth short courses with topic experts
View innovative products and novel platforms in the exhibit hall

The 2015 Next Generation Dx Summit Highlighted the Immense Opportunity and Exciting Changes Happening in the Diagnostics Industry

On August 18-20, Next Generation Dx Summit once again brought together all the major players in the diagnostics community to navigate the research advancements and technologies responsible for creating immense opportunity in the industry. Through more than 130 scientific presentations, cross-industry regulatory and reimbursement updates, and collaborative discussions throughout the active exhibit hall, attendees left with the insight needed to continue maximizing the impact the field has on precision medicine and health outcomes. A record-breaking 950+ attendees from 29 countries participated.

A special thank you to the speaking faculty, attendees, sponsors, exhibitors and media who make this event such a success each year!

Join the Community at Next Generation Dx Summit 2016

August 23-25, 2016 at the Grand Hyatt Washington, Washington, DC

Send topic suggestions and speaker referrals to:
Christina Lingham, Executive Director, Conferences
+1 781-972-5464 | clingham@healthtech.com

Contact us to learn more about exhibit and sponsorship:
Joseph Vacca, Associate Director, Business Development
+1 781-972-5431 | jvacca@healthtech.com

2015 Conference Programs

August 18-19

• Enabling Point-of-Care Diagnostics

• Predictive Cancer Biomarkers

• Companion Diagnostics

• Coverage and Reimbursement of Advanced Diagnostics

• Clinical NGS Assays

August 19-20

• Molecular Diagnostics for Infectious Disease

• Clinical Application of Cell-Free DNA

• Commercialization of Molecular Diagnostics

• Diagnostics to Guide Cancer Immunotherapy

• NGS Diagnostics: Annotation and Interpretation

• Leveraging Pharmacies for Rapid Diagnostics

2015 Short Courses - View Details

Use of FFPE/Fixed Tissues for Clinical Research
Method Validation According to CLSI Guidelines
Practical Considerations for NGS Data Analysis and Interpretation
Microfluidics for Point-of-Care
Establishing the Value of Diagnostic Tests
NGS as a Diagnostics Platform
Detection and Characterization of Circulating Biomarkers
Regulatory Compliance in Molecular Diagnostics
Use of CLIA-Waived POC and Rapid Diagnostic Tests in Community Pharmacies
NGS for Infectious Disease Diagnostics
Regulatory and Reimbursement Considerations with NGS and Other Multiplex Assays

Attendee Testimonials

"The Next Generation Dx Summit brings together key players from all facets of diagnostic development. Its format is very conducive to networking and learning from the leaders in the field. This is a great meeting for anyone who is serious about pursuing diagnostic technologies anywhere from research to commercialization."
Program Director, Fluxion Biosciences

"The meeting was excellent, one of the best I have attended, and the standard of talks matched to the schedule across the board."
Vice President, Diagnostics, GlaxoSmithKline

"As we begin to move from a centralized lab to a point-of-care setting we have faced many challenges. It has been a very rewarding meeting with the leaders in policy making along with the leaders in development all in the same place."
Pathology, Graves Gilbert Clinic

"Great conference! Most up to date data. Perfect amalgamation between industry, labs, clinicians and regulatory bodies. Highly recommended!"
Clinical Microbiology Fellow, NIH

View More Attendee Quotes